Evaluating an HIV Risk Screening Tool for Orphans and Vulnerable Children in Tanzania
NCT04517760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21080
Last updated 2020-08-18
Summary
The goal of the research was to evaluate the performance of items within the Kizazi Kipya (K2) Orphan and Vulnerable Children (OVC) HIV risk screening tool in identifying HIV-positive children, to optimize an HIV screening tool for OVC and children and adolescents in facility settings and to assess the feasibility and acceptability of home-based HIV risk screening and testing.
Conditions
- Pediatric HIV Infection
Sponsors & Collaborators
-
Tanzania Ministry of Health, Community Development, Gender, Elderly and Children
collaborator UNKNOWN -
PACT International
collaborator UNKNOWN -
Elizabeth Glaser Pediatric AIDS Foundation
lead OTHER
Principal Investigators
-
Gretchen Antelman, PhD · E. Glaser Pediatric AIDS Found
Eligibility
- Min Age
- 2 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-02-22
- Primary Completion
- 2019-09-30
- Completion
- 2019-09-30
Countries
- Tanzania
Study Locations
More Related Trials
-
Systems Analysis and Improvement to Optimize pMTCT
NCT02023658 ·Status: COMPLETED ·Phase: NA
-
Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana
NCT03088410 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe
NCT03388398 ·Status: COMPLETED
-
Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants
NCT01222130 ·Status: COMPLETED
-
HIV Point-of-Care Test Evaluation in Infants
NCT02545296 ·Status: COMPLETED ·Phase: NA
-
Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children
NCT02682810 ·Status: COMPLETED ·Phase: NA
-
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
NCT06267508 ·Status: RECRUITING
-
Dual bNAb Treatment in Children
NCT03707977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact of Point-of-Care EID for HIV-Exposed Infants
NCT03824067 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Hepatitis C Virus Infection in HIV-Infected Children
NCT00037076 ·Status: COMPLETED
-
HIV Diagnosis in Hospitalized Malawian Infants
NCT01388452 ·Status: COMPLETED ·Phase: NA
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Preventing Unplanned Pregnancies in HIV Infected Zambian Couples
NCT00067522 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
NCT00341302 ·Status: COMPLETED
-
Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
NCT00001826 ·Status: COMPLETED
-
A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
NCT00000716 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo
NCT03048669 ·Status: COMPLETED ·Phase: NA
-
Pediatric Enhanced Surveillance Study
NCT02043769 ·Status: COMPLETED
-
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
NCT00270296 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants
NCT02256631 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
NCT00000750 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
NCT01645865 ·Status: COMPLETED